Invizyne Technologies (IZTC) Stock Analysis

What Invizyne Technologies does

Invizyne Technologies Inc. is an American synthetic biochemical company that has developed SimplePath, an innovative platform. This technology is designed to synthesize a diverse range of chemicals, including vital substances like pharmaceuticals, fuels, and advanced materials, as well as food additives and entirely novel compounds. At its core, SimplePath is composed of specialized modules, each integrating one or more enzymes that collaboratively execute defined biocatalytic conversions. Established in 2014, Invizyne Technologies' operations are headquartered in Monrovia, California.

Key metrics

ETFs linked to IZTC

Broad-market and Healthcare sector ETFs an investor holding Invizyne Technologies is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how IZTC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Invizyne Technologies?

Invizyne Technologies trades under the ticker IZTC on NASDAQ.

Which exchange is IZTC listed on?

IZTC is listed on NASDAQ.

What sector does Invizyne Technologies operate in?

Invizyne Technologies is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IZTC in a portfolio?

PortView shows IZTC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.